Boston Scientific’s Watchman FLX left-atrial appendage (LAA) closure device will finally face competition in the US market with the launch of Abbott ’s Amplatzer Amulet LAA occluder.
On 16 August, the US Food and Drug Administration announced it approved Abbott’s premarket approval (PMA) application for Amplatzer Amulet to prevent thrombus embolization in patients with nonvalvular atrial...